What an AI agent reads on Respinor
An assistant's crawler fetches the page once, without running JavaScript, and reads the text, the structured data and the links. Below is what it gets from respinor.com, taken from the copy the scanner kept.
4,300
characters of text without JavaScript
none
structured data for the business
0
of 3 AI crawlers turned away at the edge
The words an agent gets
Title: Non Invasive Diaphragm Monitoring - DXT by RESPINOR · language en. First 1,800 of 4,300 characters:
Non Invasive Diaphragm Monitoring - DXT by RESPINORHomeProductExpert StatementNewsroomTeamAboutContactInvestorsThe non-invasive ultrasound-based medical deviceDXT by RESPINORNovel, non-invasive ultrasound device for accurate and continuous diaphragm monitoringEnables early detection of diaphragm dysfunction in critical care settingsSuccessfully validated in clinical studies on mechanically ventilated patientsBacked by substantial funding from H2020 and The Research Council of NorwayCE-marked and EN ISO 13485:2016 certified, ensuring regulatory compliance and qualityReady for global market adoption with ongoing efforts towards US authorizationTargets a market potential of over 350 million patients across US and EUDeveloped to become the technology of choice for assessing work of breathingContact usRead MoreWhat is DXT?DXT, or Diaphragm Excursion Technology, is a groundbreaking non-invasive medical device developed by RESPINOR that utilizes ultrasound for operator-independent, continuous monitoring of the diaphragm, the main breathing muscle, in critically ill patients. This technology aids in the early detection of diaphragm dysfunction and enhances clinical decision-making in critical care settings.Key Benefits and Clinical Applications of DXTClinically proven output: DXT measures diaphragm excursion (DE) and respiratory rate (RR) in real-time including trends. DXT has a well-established cut-off value to detect patients at increased risk of reintubation during the weaning process from MV.Medical Need: By identifying patients at increased risk of extubation failure during the weaning process from mechanical ventilation, RESPINOR DXT has the potential to improve decision making and reduce the number of emergency re-intubations, and potential morbidity associated with me
What it can say about the business
| A business type in JSON-LD | no |
| Name | no |
| Telephone | +4724022554 (a tel: link, not structured) |
| Address | no |
| Opening hours | no |
| Menu or price list | nothing |
| Cuisine in structured data | no |
| JSON-LD blocks | 0 |
The links it would act on
No booking or ordering link found; only a phone number (+4724022554). An agent has nothing to act on.
Everything here comes from fetching the homepage once as a crawler. The report turns it into a score and a list of fixes, with code to paste.